Gui-xin Li

Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma.

Xiao-fei Yang, Hui Zhou, Lin Lin, 2021, Immunology letters.

In Vitro and in Vivo Study of Individualized Cancer Immunotherapy and a Pilot Trail on Patients with Gastric Cancer

Jian-hui Cai, Shaojian Xie, Gui-xin Li, 2010 .

In vitro characterization of stem cell-like properties of drug-resistant colon cancer subline.

Dong Yang, Hai-juan Wang, Chen Lin, 2013, Oncology research.

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma

Jin Liu, Gui-xin Li, Qi-Fu Bo, 2015, Oncology letters.

In Vitro Characterization for Human Serum Albumin Binding Sorafenib, A Multi Kinase Inhibitor: Spectroscopic Study

L. Qi, Zhong Lu, Gui-xin Li, 2014, Journal of Solution Chemistry.

A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control

Wei Wang, F. Xu, Yun-hai Wang, 2014, Parasitology Research.

The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.

P. Yuan, Gui-xin Li, Jianghe Fan, 2016, Biochemical and biophysical research communications.

Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters

L. Qi, J. M. Wang, Zhong Lu, 2013, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma

M. Li, Hui Zhou, Bao-jun Shi, 2020, Chinese medical journal.

Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro

Gui-xin Li, Shuimiao Zhao, Wenhao Wang, 2015, Molecular medicine reports.